NCT05116410View on ClinicalTrials.gov

A Study of HS-20094 in Healthy Participants

PHASE1UnknownINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2022

Conditions
Type 2 Diabetes
Interventions
DRUG

HS-20094

Administrated SC

DRUG

Placebo

Administrated SC

Trial Locations (1)

110000

RECRUITING

Beijing University First Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY